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Darier disease (DD) is a rare dominant human disorder characterized by warty papules and 
plaques in seborrheic areas of the skin, which may cause a severe discomfort. Lesions are 
exacerbated by UV exposure, heat and sweating, and subject to secondary infection. Treatments 
often remain unsatisfactory. Onset usually occurs during adolescence, with highly variable 
expressivity. Histological findings in the epidermis reveal suprabasal acantholysis and two 
abnormal types of keratinocytes. Corps ronds refer to cells with small pycnotic nuclei, perinuclear 
clear halo and eosinophilic cytoplasm, while grains are compressed cells with elongated nuclei 
preferentially found in granular and cornified layers (Figure 1a-c).  
DD arises from mutations in the ATP2A2 gene encoding SERCA2, a pump transporting Ca2+ 
from the cytosol to the lumen of endoplasmic reticulum (ER) [1]. Numerous mutations have been 
described with no clear genotype/phenotype correlation [2]. At the cellular level, ATP2A2 mutations 
lead to depletion of Ca2+ ER stores and aggregation of mutant proteins, both contributing to 
permanent ER stress and apoptosis of certain keratinocytes [3-5] . Moreover, DD keratinocytes 
show defective trafficking of desmosomal proteins which could explain the acantholytic phenotype, 
and abnormal differentiation with altered labelling patterns of involucrin, keratin 14 and keratin 10 
(reviewed in [6]). Studies using monolayers of keratinocytes cultured from DD patients or normal 
keratinocytes transduced with lentiviral vectors expressing mutant SERCA2 proteins have 
contributed to unravel the molecular basis of DD [4,5]. Nevertheless, a model tool of DD displaying 
stratification and complete epidermal differentiation is needed for functional studies and testing new 
treatments . Recently, efforts have being undertaken in order to create three-dimensional models 
mimicking various dermatological conditions in vitro. For example, keratinocytes derived from 
patients suffering from epidermolytic ichthyosis  are able to reconstitute an epidermis closely 
resembling the native skin phenotype resulting that results from mutations in genes encoding 
keratins 1 and 10 [7].  A variety of models for multifactorial diseases such as atopic dermatitis and 
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psoriasis have been obtained  by altering either the environment of the reconstructed tissue or its 
gene expression profile [8-12].  
In this study, we have used epidermis reconstruction [13] from primary keratinocytes 
cultured from a DD lesion in order to reproduce in vitro the phenotype of DD epidermis.  
Keratinocytes were obtained from a surgical resection of a congenital DD lesion of the scalp 
from a 7-months-old baby. Diagnosis was based on histopathological examination and positive 
family history. In accordance with the standards of the Institute for Pathology and Genetics ethics 
committee, parental consent was obtained for DNA analysis and keratinocyte culture.  
Sequencing of the SERCA2 gene on DNA extracted from peripheral blood lymphocytes revealed 
the presence of a previously described missense mutation Thr357Lys [1]. The same mutation was 
found in blood DNA from the father affected by a mild form of the disease. When cultured as 
primary monolayers, DD keratinocytes were undistinguishable from normal cells with respect to the 
growth rate and visual aspect by phase contrast microscopy (data not shown).  
Sequencing of SERCA2 exon 8 in DNA extracted from cultured keratinocytes revealed 
heterozygosity for the Thr357Lys mutation. After amplification, DD keratinocytes were seeded at 
high density on polycarbonate filters in culture medium containing 1,5 mM Ca2+. After 24 hours, 
cells were exposed to the air-liquid interface in order to reconstruct human epidermis (RHE) in 
vitro, according to our method [13].  After 11 days of culture, a stratified epidermis was obtained, 
exhibiting abnormal features strikingly similar to those observed in DD lesions (Figure 1 d-g). The 
intercellular spaces were markedly enlarged in all suprabasal layers, suggestive of acantholysis. 
Dyskeratotic keratinocytes with the typical appearance of corps ronds and grains were observed. In 
addition, as compared to normal RHE, DD-RHE revealed an increased number of mitoses in the 
basal layer. This histopathological phenotype was found consistently in all tissues reconstructed 
with these keratinocytes.  
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The DD-RHE was further characterized using immunodetection of several maturation 
markers and compared to DD lesional skin from the patient and to control samples (Figure 2). As 
expected, healthy skin and RHE obtained from normal keratinocytes exhibited keratin 14 
expression restricted to the basal layer [13]. In contrast, keratin 14 was abnormally expressed in 
several suprabasal layers in DD-RHE, similarly to the pattern reported in lesional DD skin [4] and 
observed in our sample. The distribution of keratin 10 covers all suprabasal layers in normal skin 
and RHE [13].  Conversely, at least two layers of cells were unlabeled at basal side of DD-RHE, 
resembling the picture reported in lesional DD skin [4] and observed in this study. The distribution 
of the late differentiation marker involucrin, normally restricted to the upper spinous and granular 
layers in healthy skin, was also studied. In normal RHE, involucrin labelling appears sometimes in 
deeper layers than in vivo (Figure 2) but is never observed in the basal layer [13]. In DD-RHE, the 
distribution of involucrin is markedly abnormal, with cytoplasmic labelling over the whole 
thickness of the reconstructed tissue, reminiscent of lesional DD skin, where the expression of 
involucrin is also extended towards deeper layers than in normal skin (Figure 2), although the 
labelling is not observed in the basal layer. Premature expression of involucrin in lower spinous 
layers and even in basal layer is a common feature of DD epidermis [14].  
Our work demonstrates that RHE can be obtained from keratinocytes isolated from lesional 
skin of DD patient. The phenotype of the resulting DD-RHE presents striking similarities with 
histological characteristics of DD lesions in vivo, namely acantholysis and presence of dyskeratotic 
keratinocytes. Moreover, the abnormal differentiation process described in lesional epidermis is 
also observed in the DD-RHE after 11 days of culture.  
Undoubtfully, this work provides a new model to better investigate the onset of the cellular 
defects which result from defective SERCA2 function and progressively alter the process of 
differentiation. Moreover, pre-clinical testing of candidate drug formulations will become possible. 
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As a first step, the response of the DD-RHE to the topical or systemic application of retinoids, 
commonly used as treatments for DD, will be characterized.  
Important issues remain to be addressed. Actually, the patient behind this study suffers from 
an atypical congenital form of the disease. Reconstruction of DD-RHE will be repeated using 
biopsies from unrelated DD cases carrying different mutations. Comparison of the phenotypes of 
the resulting RHE may help to clarify the genotype/phenotype correlation, which remains elusive 
[2, 3, 5]. 
The achievement of a culture model of DD epidermis attests the feasibility of reproducing a 
pathological condition in vitro for research or therapeutic perspectives.  
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Figure Legends: 
Figure 1. Histopathological features of Darier’s disease are conserved after epidermis 
reconstruction with primary keratinocytes derived from lesional skin 
(a) Section of Darier’s disease (DD) lesion from the patient, showing epidermal hyperplasia, 
parakeratosis,  and suprabasal clefting (asterisks) due to acantholysis (scale bar : 200µm). (b,c)   
Higher magnification showing dyskeratosis with corps ronds (black arrowheads) and grains 
(arrows) (scale bars: 50 µm). (d-g) Perpendicular sections of RHE cultured from primary DD 
keratinocytes for 11 days at air-liquid interface.  Similarities to Darier native epidermis include the 
presence of grains  (d, arrow in e), corps ronds (d, black arrowhead in f), and enlargement of 
intercellular spaces (acantholysis) (d,asterisks in e and g). Frequent mitoses are seen in the basal 
layer (d, white arrowhead in f). Hematoxylin-eosin stain (scale bars: 50 µm).  
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Figure 2.  Immunohistochemical staining for keratin 14, keratin 10 and involucrin shows 
altered distribution in DD-RHE, reflecting a similar disease-linked differentiation defect both 
in vitro and in vivo 
Keratin 14 labeling (detected with antibody from Santa Cruz, CA, USA; dilution 1:50) is restricted 
to the basal layer in normal epidermis and RHE. In DD lesional skin as well as in DD-RHE, keratin 
14 is detected in basal and suprabasal layers. Keratin 10 labeling (detected with antibody from 
Dako, Glostrup, Denmark; dilution 1:100) is present in all layers except the basal layer in normal 
epidermis and RHE.  In contrast, in DD skin and DD-RHE, at least the two deepest cell layers are 
devoid of keratin 10 labeling. Involucrin immunoreactivity (detected with antibody from Sigma-
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Aldrich, Saint Louis, Oregon, USA; dilution 1:1000) is expressed in the stratum granulosum in 
normal skin and RHE. In lesional skin, involucrin labeling appears in more basally located 
keratinocytes. In DD-RHE, involucrin labeling is expressed through all cell layers of the tissue, 
including the basal layer. Immunohistochemical (peroxidase)-hematoxylin stain (scale bar: 50µm). 
 
